Corporate Presentation
About ZP
We are an international biotech company
headquartered in Denmark
Founded in 1998
ZEAL&
ZEALAND PHARMA
•
.
Peptide platform validated through two approved
products marketed by Sanofi and Novo Nordisk
~260 employees globally as of December 31, 2023
Listed on NASDAQ CPH (ZEAL.CO)
•
Market Cap on 3/31/2024: DKK 43B (USD ~6.1B)
62.6M Shares Outstanding as of March 31, 2024
Cash position*
DKK 4.1B (~USD $595M)
•
Including Jan-24 capital raise, EIB loan and RCF
OPEX guidance for 2024
•
Net operating expenses are expected to be
DKK 1,100-1,200M
Headquarters and labs outside Copenhagen, Denmark
*Cash position includes cash, cash equivalents and marketable securities. Zealand also has a
Revolving Credit Facility (RCF) with Danske Bank, off-balance sheet, of DKK 350M and a Loan
facility with the European Investment Bank of EUR 90 million in three tranches (Tranche A of
EUR 50 million is expected in Q1-2024, Tranches B and C are subject to pre-specified
milestones being met).
Based on foreign exchange rates as of March 31, 2024 DKK 6.943 = USD $1
4View entire presentation